These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 3895225)
1. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225 [TBL] [Abstract][Full Text] [Related]
2. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618 [TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
4. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium. Joiner KA; Tartanian AB; Hammer CH; Schweinle JE J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866 [TBL] [Abstract][Full Text] [Related]
5. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation. Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562 [TBL] [Abstract][Full Text] [Related]
6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296 [TBL] [Abstract][Full Text] [Related]
7. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage. Sims PJ Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. Joiner KA; Hammer CH; Brown EJ; Frank MM J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180 [TBL] [Abstract][Full Text] [Related]
9. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8. Dankert JR; Esser AF Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029 [TBL] [Abstract][Full Text] [Related]
10. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. MacKay SL; Dankert JR J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122 [TBL] [Abstract][Full Text] [Related]
12. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes. Stewart JL; Monahan JB; Brickner A; Sodetz JM Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588 [TBL] [Abstract][Full Text] [Related]
13. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. Podack ER; Tschoop J; Müller-Eberhard HJ J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822 [TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death. Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179 [TBL] [Abstract][Full Text] [Related]
15. Does complement kill E. coli by producing transmural pores? Born J; Bhakdi S Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836 [TBL] [Abstract][Full Text] [Related]
17. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement. Esser AF; Sodetz JM Methods Enzymol; 1988; 162():551-78. PubMed ID: 3226325 [No Abstract] [Full Text] [Related]
18. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. Kochi SK; Johnson RC; Dalmasso AP J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266 [TBL] [Abstract][Full Text] [Related]
19. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores. Doorduijn DJ; Heesterbeek DAC; Ruyken M; de Haas CJC; Stapels DAC; Aerts PC; Rooijakkers SHM; Bardoel BW PLoS Pathog; 2021 Nov; 17(11):e1010051. PubMed ID: 34752492 [TBL] [Abstract][Full Text] [Related]
20. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization. Tschopp J; Podack ER; Müller-Eberhard HJ J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]